When Jeanne Marrazzo was introduced as director of the US Nationwide Institute of Allergy and Infectious Ailments (NIAID) final 12 months, she turned one of many main public well being decision-makers on the planet. Changing Anthony Fauci, whose tenure throughout the covid-19 pandemic made him a family title, the stakes have by no means been increased for the company’s latest boss.

Having spent many years working throughout HIV prevention and sexually transmitted illnesses, in addition to overseeing therapeutic interventions for covid-19, Marrazzo is now in control of NIAID’s $6.6 billion annual finances – and the way forward for the US response to infectious illness.

That entails working with the institute’s 21 laboratories throughout the nation, main the struggle towards ebola and HIV and spearheading efforts to develop new vaccines, therapies, diagnostics and applied sciences.

On the prime of Marrazzo’s to-do record is tackling antimicrobial resistance (AMR), or drug-resistant superbugs, that are predicted to trigger 10 million deaths per 12 months by 2050 at an annual value of $1 trillion to the worldwide economic system. In Could, the UK’s former chief medical officer warned that the rise of those pathogens might make the pandemic look “minor” and that the difficulty is extra acute than local weather change.

Our warming world is partly chargeable for rising charges of AMR, with shifting local weather circumstances across the globe serving to micro organism reminiscent of Salmonella and cholera-causing Vibrio to outlive – and evade our present antibiotic weaponry fully. Right here, Marrazzo outlines the issues we must always maybe worry most, in addition to some promising developments on the horizon.

Charlotte Lytton: In what methods is the…